In yesterday’s Wall Street session, Tenon Medical Inc (NASDAQ:TNON) shares traded at $2.00, up 57.48% from the previous session.
2 analysts cover Tenon Medical Inc (NASDAQ:TNON), according to research data. The consensus rating among analysts is ‘Buy’. As we calculate the median target price by taking the range between a high of $30.00 and a low of $6.00, we find $18.00. Given the previous closing price of $1.27, this indicates a potential upside of 1317.32 percent. TNON stock price is now 12.77% away from the 50-day moving average and -80.44% away from the 200-day moving average. The market capitalization of the company currently stands at $4.32M.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
The stock has received a hold rating from 0 analysts and a buy rating from 2. Brokers who have rated the stock have averaged $18.00 as their price target over the next twelve months.
In other news, VAN DICK STEVEN M, Chief Financial Officer bought 50,000 shares of the company’s stock on Jun 14. The stock was bought for $13,650 at an average price of $0.27. Upon completion of the transaction, the Chief Financial Officer now directly owns 100,416 shares in the company, valued at $0.2 million. An SEC document containing details of the transaction can be found on the SEC’s website. On May 23, Chief Technology Officer GINN RICHARD sold 64,990 shares of the business’s stock. A total of $81,887 was realized by selling the stock at an average price of $1.26. This leaves the insider owning 85,318 shares of the company worth $0.17 million. Insiders disposed of 92,781 shares of company stock worth roughly $0.19 million over the past 1 year. A total of 19.23% of the company’s stock is owned by insiders.
On Monday morning Tenon Medical Inc (NASDAQ: TNON) stock kicked off with the opening price of $1.2400. During the past 12 months, Tenon Medical Inc has had a low of $0.77 and a high of $31.10. As of last week, the company has a debt-to-equity ratio of 0.89, a current ratio of 1.15, and a quick ratio of 1.07. The fifty day moving average price for TNON is $1.7738 and a two-hundred day moving average price translates $10.2238 for the stock.
The latest earnings results from Tenon Medical Inc (NASDAQ: TNON) was released for Jun, 2023. According to the Medical Devices Company, earnings per share came in at -$0.33, beating analysts’ expectations of -$0.38 by 0.05. This compares to -$0.65 EPS in the same period last year. The net profit margin was -1215.59% and return on equity was -252.14% for TNON. The company reported revenue of $0.74 million for the quarter, compared to $0.14 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 450.37 percent. For the current quarter, analysts expect TNON to generate $1.07M in revenue.
Tenon Medical Inc(TNON) Company Profile
Tenon Medical, Inc., a medical device company, engages in the development of surgical implant systems to treat severe lower back pain in the United States and Puerto Rico. The company offers CATAMARAN SI-Joint Fusion System to fuse sacroiliac joints (SI-Joints) to treat SI-Joint dysfunction that often causes severe lower back pain; and features fixation device that passes through the axial and sagittal planes of the ilium and sacrum, as well as stabilizes and transfixes the SI joints. Tenon Medical, Inc. was incorporated in 2012 and is headquartered in Los Gatos, California.
